Your browser is no longer supported. Please, upgrade your browser.
AGN Allergan plc daily Stock Chart
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-13.47 Insider Own0.20% Shs Outstand333.82M Perf Week-0.16%
Market Cap58.64B Forward P/E10.49 EPS next Y16.75 Insider Trans-10.12% Shs Float333.82M Perf Month1.43%
Income-4501.80M PEG- EPS next Q4.12 Inst Own88.60% Short Float1.10% Perf Quarter5.29%
Sales16.04B P/S3.66 EPS this Y-543.10% Inst Trans0.57% Short Ratio1.43 Perf Half Y-1.68%
Book/sh216.16 P/B0.81 EPS next Y4.23% ROA-1.80% Target Price207.00 Perf Year-29.03%
Cash/sh6.09 P/C28.85 EPS next 5Y6.22% ROE-3.00% 52W Range142.81 - 256.80 Perf YTD7.38%
Dividend2.88 P/FCF12.36 EPS past 5Y11.27% ROI-2.10% 52W High-31.90% Beta1.14
Dividend %1.64% Quick Ratio0.90 Sales past 5Y21.90% Gross Margin86.00% 52W Low22.46% ATR3.53
Employees17800 Current Ratio1.10 Sales Q/Q2.80% Oper. Margin-23.30% RSI (14)57.75 Volatility1.48% 1.98%
OptionableYes Debt/Eq0.37 EPS Q/Q87.30% Profit Margin-13.10% Rel Volume0.39 Prev Close175.66
ShortableYes LT Debt/Eq0.36 EarningsJul 26 BMO Payout- Avg Volume2.56M Price174.88
Recom2.20 SMA201.32% SMA506.89% SMA2003.08% Volume416,228 Change-0.44%
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-19-17Reiterated RBC Capital Mkts Outperform $277 → $250
Oct-17-17Reiterated UBS Buy $275 → $255
Oct-02-17Reiterated Barclays Equal Weight
Sep-25-17Reiterated RBC Capital Mkts Outperform $285 → $277
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Jul-13-18 10:36AM  Aurinia Pharmaceuticals Has Lots of Upside Potential InvestorPlace
Jul-11-18 06:59AM  Examining Allergan: Cramer Goes 'Off the Charts'
Jul-10-18 07:38PM  Don't get too excited about Botox maker Allergan CNBC Videos
06:59PM  Cramer Remix: This hidden stock has great long-term prospectsbut theres a catch CNBC
06:43PM  Cramer: Don't get your hopes up with the stock of Botox m... CNBC Videos
06:33PM  Cramer: Don't get your hopes up with the stock of Botox maker Allergan CNBC
11:58AM  Top Analyst Reports for Union Pacific, 21st Century Fox & BP Zacks
11:54AM  Trump Tweets Threat to Pfizer but Investors Shrug it Off InvestorPlace
08:00AM  Allergan Expands REFRESH® Portfolio With New REFRESH® REPAIR Lubricant Eye Drops PR Newswire
Jul-09-18 04:25PM  This Blockbuster Drug Could Help Allergan Boost Its 2018 Numbers Investor's Business Daily
12:03PM  Allergan Stock Is Worth a Look for Long-Term Investors InvestorPlace
Jul-06-18 10:56AM  5 Pharmaceutical and Biotech Stocks to Consider for July InvestorPlace
06:00AM  5 Bargain Biotechs Poised for Big Short-Term Gains Investopedia
Jul-03-18 08:41AM  Adamis (ADMP) Surges Following Novartis Deal for Symjepi Zacks
08:39AM  The Zacks Analyst Blog Highlights: Bank of America, Wells Fargo, Honeywell, Allergan and Enterprise Products Zacks
Jul-02-18 12:01PM  Top Research Reports for Bank of America, Wells Fargo & Honeywell Zacks
09:30AM  Is Allergan (AGN) a Suitable Stock for Value Investors Now? Zacks
09:30AM  Has Allergan plc (AGN) Outpaced Other Medical Stocks This Year? Zacks
09:30AM  AGN vs. AMPH: Which Stock Is the Better Value Option? Zacks
Jun-28-18 09:00AM  Allergan Eases Manual Data Entry and Contract Management Pains with Pramatas Billing Accuracy Solution GlobeNewswire
08:01AM  Allergan's Study in Chronic Migraine Receives Migraine Research Award at the American Headache Society's 60th Annual Scientific Meeting PR Newswire
07:00AM  Healthcare: Drug Pricing Concerns Weigh on Valuations, Creating Opportunities Morningstar
Jun-27-18 07:00AM  Stock Market Outlook: Some Values to Be Found in Defensive Sectors Morningstar
Jun-26-18 08:00AM  Allergan to Report Second Quarter 2018 Earnings and Host Conference Call and Webcast PR Newswire
Jun-25-18 02:54PM  Allergan plcs (NYSE:AGN) Shift From Loss To Profit Simply Wall St.
07:10AM  Free Technical Research on Akorn and Three More Generic Drugs Equities ACCESSWIRE
Jun-21-18 05:15PM  Allergan Promotes Male Botox Users With Big Campaign Bloomberg Video
05:15PM  Allergan Promotes Male Botox Users With Big Campaign Bloomberg
05:00AM  Wanted: Wrinkled Men Not Afraid of Needles for Brotox Revival Bloomberg
Jun-20-18 01:36PM  Boston Scientific, Masco, MasterCard, Allergan & Paypal CNBC Videos
Jun-15-18 09:32AM  Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play InvestorPlace
09:27AM  Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals Zacks
Jun-14-18 05:05PM  Is Goldman Sachs Going to Be the Next Allergan?
11:31AM  Allergan (AGN) Presents Positive Data on Glaucoma Candidate Zacks
08:28AM  Allergan appoints former Abbott executive to its board Reuters
08:25AM  Detailed Research: Economic Perspectives on Stein Mart, Asbury Automotive Group, Sprint, The Kraft Heinz, Allergan plc, and Fitbit What Drives Growth in Today's Competitive Landscape GlobeNewswire
08:00AM  Allergan Continues Active Board Refreshment Process PR Newswire
Jun-13-18 08:00AM  Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant for IOP Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension PR Newswire
Jun-12-18 10:14AM  Allergan's Second Anti-CGRP Drug Positive in Mid-Stage Study Zacks
Jun-11-18 09:14AM  Allergan oral migraine drug succeeds in study Reuters
09:04AM  What to Do After Axovant Sciences Ltd Skyrockets Three-fold in a Month InvestorPlace
08:00AM  Allergan's Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy and Safety in Episodic Migraine Prevention in a Phase 2b/3 Clinical Trial PR Newswire
Jun-08-18 10:27AM  Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant Zacks
09:45AM  Bernstein: What Activism Means For Allergan Shareholders Benzinga
Jun-07-18 10:43PM  Asian shares fall ahead of G7 summit, central bank meetings Associated Press +5.08%
04:39PM  NXP Semiconductors and Allergan rise; Smucker slips Associated Press
04:04PM  Deals of the day-Mergers and acquisitions Reuters
01:25PM  Food movers in the blitz. Plus, the investor who reported... CNBC Videos
01:19PM  Allergan on an upswing, Vail Resorts soars, Johnson & Johnson dips Yahoo Finance
01:12PM  Icahn targets Allergan amid activist investor campaign American City Business Journals
11:08AM  Allergan, Vail Resorts and Johnson & Johnson are the Yahoo Finance charts of the day. Yahoo Finance Video
09:24AM  Stocks to Watch: Boeing, Tesla, Allergan, Amazon, Alibaba, Smucker The Wall Street Journal
09:05AM  The Market In 5 Minutes: Allergan, Solars, Jobless Claims And More Benzinga
08:30AM  Allergan and Actress Shay Mitchell Join Forces to Inspire Women to Know Their Birth Control PR Newswire
08:20AM  Today's Research Reports on Trending Tickers: Endo International and Allergan ACCESSWIRE
08:12AM  Deals of the day-Mergers and acquisitions Reuters
07:55AM  US STOCKS-Futures inch higher as Allergan, banks gain Reuters
07:28AM  Jamie Dimon, Warren Buffett, Allergan and Google - 5 Things You Must Know
07:02AM  Carl Icahn acquires stake in Allergan Fox Business Videos
Jun-06-18 07:50PM  [$$] Allergan Needs a New Wrinkle The Wall Street Journal
06:45PM  Icahn buys small stake in drugmaker Allergan: sources Reuters
05:00PM  Carl Icahn reportedly building small position in Allergan, joining David Tepper CNBC
04:47PM  Icahn Is Said to Build Small Position in Drugmaker Allergan Bloomberg
04:47PM  Icahn Builds a Small Position in Drugmaker Allergan Bloomberg
03:21PM  [$$] Investors Push Allergan for Management Changes, After Half-Hearted Strategic Review The Wall Street Journal
12:25PM  [$$] Allergan Needs a New Wrinkle The Wall Street Journal
09:13AM  Allergan Requests Shareholders to Veto Management Change Zacks
09:12AM  Your first trade for Wednesday, June 6 CNBC
Jun-05-18 08:34PM  Allergan plc (NYSE:AGN): When Will It Breakeven? Simply Wall St.
04:14PM  [$$] Investors Push Allergan for Management Changes The Wall Street Journal
02:51PM  Two Allergan shareholders call for split of chairman-CEO role Reuters
02:07PM  Allergan responds to Appaloosa's calls for management cha... CNBC Videos
01:42PM  Allergan Responds to Public Shareholder Letter PR Newswire
12:43PM  Appaloosa calls for Allergen management change in letter CNBC Videos
11:54AM  Tepper says Allergan should split CEO and chairman role and overhaul management CNBC
11:28AM  Activist investor Appaloosa asks Allergan for management changes MarketWatch
11:17AM  Appaloosa calls for Allergan management change CNBC Videos
10:54AM  Hedge fund Appaloosa asks Allergan to split chairman-CEO position Reuters
08:00AM  Allergan Teams Up with a Host of Celebrities to Encourage Alzheimer's Patients and their Caregivers to Hold on to Hope PR Newswire
12:07AM  [$$] Appaloosa calls for governance changes at Allergan Financial Times
Jun-04-18 04:00AM  Judges Criticize Allergan's Use of Mohawk Tribe's Sovereignty Bloomberg
Jun-01-18 05:09PM  FDA Delays Amgen-Allergan Copycat Herceptin, Gives Roche Breathing Room Investor's Business Daily
May-31-18 09:17AM  Allergan recalls out-of-sequence birth control pills American City Business Journals
May-30-18 08:09PM  [$$] Allergan To Sell Businesses in Bid To Appease Shareholders The Wall Street Journal
08:00PM  Allergan Pursues Strategic Divestitures; Specialty Retailers Shake Out -- ICYMI
07:15PM  CoolSculpting® And #WeAllGrow Latina Network Host Discussion On The Perceptions Of Beauty And Body In The Latina Community PR Newswire
05:37PM  Allergan to sell women's health, infectious disease units Reuters
04:28PM  Allergan Won't Engage In 'Fire Sale' As It Seeks To Divest Two Units Investor's Business Daily
02:20PM  Botox Maker's Puny Disposals Wouldn't Move the Needle Bloomberg
01:18PM  [$$] Allergan To Sell Businesses in Bid To Appease Shareholders The Wall Street Journal
01:13PM  Dick's Sporting Goods soars on earnings, Allergan's massive birth control recall, Fox sets date for Disney vote, Tesla Model S crashes Yahoo Finance Video
12:05PM  Allergan Says It's Looking to Sell Two of Its Units, But Not at Fire-Sale Prices
11:59AM  Why Is Allergan (AGN) Down 4.1% Since its Last Earnings Report? Zacks
11:41AM  Allergan Looks To Sell Women's Health, Infectious Disease Businesses Benzinga
11:28AM  Allergan plans sales of women's health, infectious disease units Reuters
11:09AM  Fallout from Allergan's birth control recall Fox Business Videos
10:54AM  TherapeuticsMD's therapy for menopause-related condition gets approval Reuters
10:39AM  Allergan Recalls Taytulla Oral Contraceptives, Stock Down Zacks
10:10AM  Allergan plans sales of women's health, infectious disease units Reuters
09:41AM  Allergan to sell women's health and infectious disease un... CNBC Videos
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meury WilliamEVP & Chief Commercial OfficerMay 17Option Exercise68.1121,2521,447,47440,154May 21 05:21 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Sale154.5924,4253,775,86115,729May 21 05:21 PM
Hilado Maria TeresaExecutive Vice PresidentMar 15Buy167.39895149,81426,530Mar 19 09:36 AM
WALSH MATTHEW MEVP, Chief Financial OfficerMar 08Buy153.961,000153,96025,416Mar 08 10:44 AM
SAUNDERS BRENT LChairman, President and CEOMar 08Buy152.533,300503,349180,931Mar 08 10:25 AM
Boccuzi Joseph HDirectorMar 05Buy143.42900129,0781,862Mar 09 04:31 PM
WALSH MATTHEW MEVP, Chief Financial OfficerFeb 21Buy160.942,000321,88024,416Feb 22 04:25 PM
Meury WilliamChief Commercial OfficerFeb 14Option Exercise63.1723,6131,491,73778,600Feb 16 05:10 PM
Meury WilliamChief Commercial OfficerFeb 14Sale160.6258,8799,457,36919,721Feb 16 05:10 PM
BODINE CHRIS WDirectorDec 07Buy164.773,030499,25317,098Dec 07 05:21 PM
SAUNDERS BRENT LChairman, President and CEODec 06Buy164.744,600757,794186,377Dec 06 12:31 PM
COUGHLIN CHRISTOPHER JDirectorDec 05Buy163.3010,0001,633,00014,446Dec 05 04:16 PM
Meury WilliamChief Commercial OfficerDec 01Option Exercise78.8811,807931,33668,828Dec 04 06:21 PM
Meury WilliamChief Commercial OfficerDec 01Sale173.8911,8072,053,11957,021Dec 04 06:21 PM